Prospective evaluation of early virological response associated with peginterferon alfa-2a (40KD) (Pegasys (R)) and ribavirin from a phase IV, randomized study examining the effects of treatment duration-in hepatitis C patients infected with genotype 1.
| Contribuinte(s) |
Universidade Estadual Paulista (UNESP) |
|---|---|
| Data(s) |
20/05/2014
20/05/2014
01/10/2002
|
| Formato |
364A-364A |
| Identificador |
Hepatology. Philadelphia: W B Saunders Co, v. 36, n. 4, p. 364A-364A, 2002. 0270-9139 http://hdl.handle.net/11449/38496 WOS:000178301700787 |
| Idioma(s) |
eng |
| Publicador |
W B Saunders Co |
| Relação |
Hepatology |
| Direitos |
closedAccess |
| Tipo |
info:eu-repo/semantics/conferenceObject |
